IL4 and COVID-19: The tissue expressions of IL-4 and sphingosine-1, a marker for M2 subtype macrophages, were found to be significantly increased in post-mortem lungs from COVID-19 patients compared with those from patients infected with influenza virus and those of control patients [140].